Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 7/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | EBP | Q15125 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | WNT1 | P04628 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17273299 | 0.98 | KDM1A (0.46) | KDM1APDK1DRD1ALOX15KEAP1 | |
| SCHEMBL9801679 | 0.89 | KEAP1 (0.52) | KDM1APDK1DRD1KEAP1SMN1; SMN2 | |
| SCHEMBL14613087 | 0.89 | KEAP1 (0.52) | KDM1APDK1DRD1KEAP1SMN1; SMN2 | |
| SCHEMBL17277324 | 0.87 | KEAP1 (0.46) | KDM1APDK1DRD1KEAP1SMN1; SMN2 | |
| SCHEMBL10296636 | 0.84 | KDM1A (0.47) | KDM1APDK1DRD1DRD3ADORA2A | |
| SCHEMBL20807806 | 0.83 | — | — | |
| SCHEMBL24508777 | 0.82 | DRD3 (0.49) | KDM1APDK1DRD1DRD3EBP | |
| SCHEMBL9801716 | 0.82 | DRD3 (0.49) | KDM1APDK1DRD1DRD3EBP | |
| SCHEMBL26972530 | 0.82 | DRD3 (0.49) | KDM1APDK1DRD1DRD3EBP | |
| SCHEMBL12234718 | 0.82 | KDM1A (0.51) | KDM1APDK1DRD1KEAP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115703731-B | Imide compound, preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-118344917-A | Lubricating oil composition and preparation method thereof | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-116789582-A | Imide compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-115703731-A | Imide compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-02-17 | — | — | CN | claimed |
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2015-11-26 | — | — | US | claimed |
| EP-2934469-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | Colgate-Palmolive Company (US) | 2015-10-28 | — | — | EP | claimed |
| WO-2014098871-A2 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | COLGATE-PALMOLIVE COMPANY (US) | 2014-06-26 | — | — | WO | claimed |
| CN-115703731-B | Imide compound, preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-118344917-A | Lubricating oil composition and preparation method thereof | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2024104968-A1 | PYRAZOLOPYRROLOPYRIDAZINES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2024-05-23 | — | — | WO | disclosed |
| CN-116789582-A | Imide compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-115703731-A | Imide compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-02-17 | — | — | CN | disclosed |
| WO-2023007009-A1 | PYRAZOLOPYRIMIDINES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2023-02-02 | — | — | WO | disclosed |
| CN-102037039-B | Hardenable compositions based on silylated polyurethanes | HENKEL AG & CO KGAA | 2013-08-21 | — | — | CN | disclosed |
| CN-103249779-A | Curable composition | CONSTR RES & TECH GMBH | 2013-08-14 | — | — | CN | disclosed |
| CN-102741321-A | Polyether block copolymers and compositions that can be obtained therefrom | HENKEL AG & CO KGAA | 2012-10-17 | — | — | CN | disclosed |
| CN-102037039-A | Hardenable compositions based on silylated polyurethanes | HENKEL AG & CO KGAA | 2011-04-27 | — | — | CN | disclosed |
| CN-1256359-C | Monomer-free reactive polyurethane adhesion promoters | HENKEL KGAA (DE) | 2006-05-17 | — | — | CN | disclosed |
| CN-1402742-A | Adhesion promoters for monomer-free reactive polyurethanes | HENKEL KGAA (DE) | 2003-03-12 | — | — | CN | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150335547-A1 | ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS | MCOLN3, TAS2R39, TAS2R40 | KDM1A 2901/4885PDK1 3257/4885DRD1 3906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.